Interpret recent findings in lung cancer genetics and epigenomics to improve diagnosis, MRD detection, and monitoring of therapeutic response.

 Describe the latest drug developments in thoracic oncology and their relevance to clinical decision-making.

 Apply current evidence-based lung cancer screening strategies, including imaging and liquid biopsy techniques, to enhance early detection.

 Incorporate new multidisciplinary findings into current standards of care for lung cancer treatment.

 Critically appraise newly approved therapies and clinical trial data in lung cancer care to optimize treatment planning across disease stages.

 Differentiate among current data regarding the application of adjuvant and/or  neoadjuvant, chemotherapy and immunotherapy for metastatic lung cancer.

Select appropriate current regimens based on patient and tumor characteristics for newly diagnosed patients.